Kane M A, Portanova L B, Kelley K, Holley M, Ross S E, Boose D, Escobedo-Morse A, Alvarado B
Medical Oncology Section, Denver Veterans Affairs Medical Center, CO 80220.
Peptides. 1994;15(6):993-1001. doi: 10.1016/0196-9781(94)90062-0.
Swiss 3T3 cells contained substantial amounts of soluble and specific [125I]GRP binders. Like the membrane-associated GRP receptor, they were of high affinity, saturable, bound to GRP(14-27) affinity gels, and exhibited specificity for GRP(14-27) binding. They differed in that acid or freezing destroyed specific binding, specific binding exhibited different time and temperature effects, no detergent was required for their solubilization, ammonium sulfate fractionation yielded different profiles, the M(rs) were lower, GRP(1-16) also blocked binding, and a polyclonal anti-GRP receptor antiserum did not bind on Western blots. The isolated, soluble GRP binding protein(s) rapidly degraded [125I]GRP. These soluble GRP binding proteins may play a role in the regulation of the mitogenic effects of GRP on these cells.
瑞士3T3细胞含有大量可溶性和特异性的[125I]胃泌素释放肽结合蛋白。与膜相关的胃泌素释放肽受体一样,它们具有高亲和力、可饱和性,能与胃泌素释放肽(14 - 27)亲和凝胶结合,并对胃泌素释放肽(14 - 27)结合表现出特异性。它们的不同之处在于,酸或冷冻会破坏特异性结合,特异性结合表现出不同的时间和温度效应,其溶解不需要去污剂,硫酸铵分级分离产生不同的图谱,分子量较低,胃泌素释放肽(1 - 16)也能阻断结合,并且多克隆抗胃泌素释放肽受体抗血清在蛋白质免疫印迹中不结合。分离出的可溶性胃泌素释放肽结合蛋白能快速降解[125I]胃泌素释放肽。这些可溶性胃泌素释放肽结合蛋白可能在胃泌素释放肽对这些细胞的促有丝分裂作用的调节中发挥作用。